FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
PARAPLATIN
carboplatin
LOE Approaching
Engine Biosciences
INJECTION · INJECTABLE
1989
NDA30/100
PARAPLATIN
carboplatin
LOE Approaching
Engine Biosciences
INTRAVENOUS · INJECTABLE
2003
NDA30/100
PAREDRINE
hydroxyamphetamine hydrobromide
LOE Approaching
PhotoPharmics
OPHTHALMIC · SOLUTION/DROPS
1969
NDA30/100
PAREMYD
hydroxyamphetamine hydrobromide; tropicamide
LOE Approaching
OPHTHALMIC · SOLUTION/DROPS
1992
NDA30/100
PARLODEL
bromocriptine mesylate
LOE Approaching
ORAL · TABLET
dysfunctions associated with hyperprolactinemia including amenorrhea withwithout galactorrhea+8
1978
NDA30/100
PARNATE
tranylcypromine sulfate
LOE Approaching
ORAL · TABLET
major depressive disorder (MDD) in adult patientsdrug interactions+1
1961
NDA30/100
PASKALIUM
potassium aminosalicylate
LOE Approaching
ORAL · TABLET
1955
NDA30/100
PATADAY ONCE DAILY RELIEF
olopatadine hydrochloride
LOE Approaching
Alcon
OPHTHALMIC · SOLUTION/DROPS
2004
NDA30/100
PATADAY TWICE DAILY RELIEF
olopatadine hydrochloride
LOE Approaching
Alcon
OPHTHALMIC · SOLUTION/DROPS
1996
NDA30/100
PATANASE
olopatadine hydrochloride
LOE Approaching
Novartis
NASAL · SPRAY, METERED
2008
NDA30/100
PATHILON
tridihexethyl chloride
LOE Approaching
Pfizer
ORAL · TABLET
1954
NDA30/100
PATHOCIL
dicloxacillin sodium
LOE Approaching
Thayer Medical
ORAL · CAPSULE
1968
NDA30/100
PATHOCIL
dicloxacillin sodium
LOE Approaching
Thayer Medical
ORAL · FOR SUSPENSION
1968
NDA30/100
PAVULON
pancuronium bromide
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1972
NDA30/100
PAXIL
paroxetine hydrochloride
LOE Approaching
ORAL · CAPSULE
1998
NDA30/100
PAXIL
paroxetine hydrochloride
LOE Approaching
ORAL · SUSPENSION
1997
NDA30/100
PAXIL
paroxetine hydrochloride
LOE Approaching
ORAL · TABLET
anxiety
1992
NDA30/100
PAXIL CR
paroxetine hydrochloride
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
anxiety
1999
NDA30/100
PAXIPAM
halazepam
LOE Approaching
Merck & Co.
ORAL · TABLET
1981
NDA30/100
PBZ
tripelennamine citrate
LOE Approaching
Novartis
ORAL · ELIXIR
1948
NDA30/100
PBZ-SR
tripelennamine hydrochloride
LOE Approaching
Novartis
ORAL · TABLET, EXTENDED RELEASE
1956
NDA30/100
PCE
erythromycin
LOE Approaching
R-Pharm US
ORAL · TABLET, COATED PARTICLES
1986
NDA30/100
PEDIAPRED
prednisolone sodium phosphate
LOE Approaching
ORAL · SOLUTION
the following conditions: 1systemic lupus erythematosus+12
1986
NDA30/100
PEDIATRIC ADVIL
ibuprofen
LOE Approaching
GSK
ORAL · SUSPENSION/DROPS
1998
SMNDA30/100